Portfolio and Pipeline

No two reproductive health journeys are alike.

That's why Granata Bio is building a comprehensive pipeline of investigational therapies with the goal of expanding choice, improving access, and unlocking new possibilities for patients and their care teams.

Portfolio

Patients treated with drugs used to achieve pregnancy should be evaluated and monitored by health care professionals experienced in the field of reproductive medicine.

Pipeline

Pipeline products are under investigation and have not been proven safe and effective for the potential indication.

MiloPhene™️ is a registered trademark of Granata Bio Corporation.

*Strategic Partnership for Phase III Clinical Study | IBSA Group retains commercial rights to Progesterone-IBSA